Valuation: Burning Rock Biotech Limited

Market Cap 808M 119M 105M 96.53M 89.06M 169M 11.37B 172M 1.15B 452M 5.58B 448M 438M 19.3B P/E 2024
-1.46x
P/E 2025 -27.1x
Enterprise Value 370M 54.66M 47.93M 44.25M 40.82M 77.41M 5.21B 78.74M 528M 207M 2.56B 205M 201M 8.85B EV / Sales 2024
0.06x
EV / Sales 2025 2x
Free-Float
61.34%
Yield 2024 *
-
Yield 2025 -
1 day-3.42%
1 week+15.07%
Current month+35.01%
1 month+27.97%
3 months-28.68%
6 months-51.50%
Current year-43.92%
1 week 9.36
Extreme 9.36
12.89
1 month 6.79
Extreme 6.79
12.89
Current year 6.79
Extreme 6.79
41.72
1 year 4.32
Extreme 4.32
41.72
3 years 2.18
Extreme 2.18
41.72
5 years 2.18
Extreme 2.18
286
10 years 2.18
Extreme 2.18
397.5
Manager TitleAgeSince
Corporate Officer/Principal - 01/01/2014
Chief Executive Officer 48 01/01/2014
Director of Finance/CFO - 27/09/2024
Director TitleAgeSince
Director/Board Member 63 01/08/2016
Chairman 48 -
Director/Board Member 55 01/06/2014
Date Insider Type Main position Quantity % Market Cap.
26/06Buy

Chief Executive Officer

24,900 0.0283%
31/03Buy

Chief Executive Officer

314,870 0.3584%
18/03
Northern Light Venture Capital Development Ltd.
OtherCompany 11,880,245 13.5213%
Change 5-day change 1-year change 3-year change Capi.($)
-3.42%+15.07%+167.98%-50.66% 119M
+0.64%-2.35%+14.96%+3.27% 9.61B
-0.44%+0.49%+11.35%-1.26% 1.29B
+1.53%-2.98% - - 1.28B
+0.23%+3.69%+1.58%-11.68% 1.07B
+4.29%-6.79%+52.42%+27.38% 628M
+3.53%+0.12%-22.73% - 585M
+1.89%-0.69%+105.91%+166.01% 416M
+0.72%+0.43%-12.75%-18.30% 410M
+3.64%-4.74%-57.88%-81.32% 262M
Average +1.26%+0.44%+28.98%+4.18% 1.57B
Weighted average by Cap. +0.90%-1.54%+15.52%+4.98%

Financials

2024 2025
Net sales 516M 76.12M 66.76M 61.62M 56.85M 108M 7.26B 110M 736M 288M 3.56B 286M 280M 12.32B 540M 79.63M 69.83M 64.46M 59.47M 113M 7.59B 115M 770M 301M 3.73B 299M 292M 12.89B
Net income -347M -51.15M -44.86M -41.41M -38.2M -72.44M -4.88B -73.69M -494M -194M -2.39B -192M -188M -8.28B -55.35M -8.17M -7.16M -6.61M -6.1M -11.57M -779M -11.77M -78.95M -30.93M -382M -30.66M -30M -1.32B
Net Debt -474M -69.9M -61.3M -56.59M -52.21M -99M -6.67B -101M -676M -265M -3.27B -262M -257M -11.31B -438M -64.59M -56.64M -52.29M -48.24M -91.47M -6.16B -93.04M -624M -245M -3.02B -242M -237M -10.45B
Logo Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Employees
667
Date Price Change Volume
10/07/26 USD 11.30 -3.42% 25,689
09/07/26 USD 11.70 -0.43% 25,342
08/07/26 USD 11.75 +9.35% 39,924
07/07/26 USD 10.75 +4.02% 89,925